BioSig Technologies, Inc.
BSGM
$4.11
$0.235.93%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -67.50% | -3.70% | 122.22% | -72.34% | -85.45% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -67.50% | -3.70% | 122.22% | -72.34% | -85.45% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -67.50% | -3.70% | 122.22% | -65.79% | -81.65% |
| SG&A Expenses | 71.26% | -40.63% | -49.61% | -35.73% | -40.37% |
| Depreciation & Amortization | 103.85% | -63.10% | -47.92% | -28.49% | -9.04% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.77% | -48.90% | -55.66% | -40.20% | -41.55% |
| Operating Income | -47.01% | 48.96% | 55.78% | 40.04% | 41.17% |
| Income Before Tax | -49.57% | 60.67% | 63.96% | 48.01% | 45.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -49.57% | 60.67% | 63.96% | 48.01% | 45.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 96.27% | 95.88% | 102.56% | 122.45% | -280.25% |
| Net Income | -46.08% | 61.21% | 64.43% | 48.98% | 43.53% |
| EBIT | -47.01% | 48.96% | 55.78% | 40.04% | 41.17% |
| EBITDA | -46.03% | 48.75% | 55.88% | 40.18% | 41.52% |
| EPS Basic | 46.29% | 80.76% | 79.17% | 68.82% | 64.63% |
| Normalized Basic EPS | 45.28% | 75.04% | 76.05% | 66.30% | 62.45% |
| EPS Diluted | 46.29% | 80.76% | 79.17% | 68.82% | 64.63% |
| Normalized Diluted EPS | 45.28% | 75.04% | 76.05% | 66.30% | 62.45% |
| Average Basic Shares Outstanding | 109.92% | 102.57% | 90.69% | 84.09% | 70.64% |
| Average Diluted Shares Outstanding | 109.92% | 102.57% | 90.69% | 84.09% | 70.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |